Basal cell carcinoma (BCC) is the most common, and one of the least serious, forms of skin cancer. It tends to grow slowly and rarely spreads to other organs.
Also known as
Symptoms and signs
Pink or skin-coloured lump with pearly consistency
Irritated, sore or rough patch of skin which bleeds and/or forms a crust which does not heal after 3 months
Exposure to ultraviolet light, often prolonged daily exposure (e.g. occupational); solarium (artificial tanning) use
Exposure to arsenic or arc welding (often occupational)
Prognosis / outcome
Basal cell carcinoma
Basal cell carcinoma
Avoid unnecessary prolonged exposure to sunlight. Protect against ultraviolet radiation with sunscreen, hats, protective clothing, sunglasses and shade.
Nicotinamide (vitamin B3): 1000mg per day reduces the risk of future basal cell carcinoma
Yearly full-body skin check allows basal cell carcinoma to be detected at an early, more easily treated stage
News / blog articles
Recommended web links
Basal cell carcinoma (BCC) affects approximately 50 per cent of Australians (Staples 2006). It tends to grow slowly and almost always remains confined to one location. BCC can be treated by surgical removal and, in some cases, cryotherapy (freezing) or applying a cream.
What does BCC look like?
Basal cell carcinomas can be thin or thick and their appearance varies. They are most common on areas that have long-term exposure to the sun, such as the face and arms, although they are also common on the back and chest.
Nodular basal cell carcinoma
Nodular basal cell carcinoma (nBCC) often appears as a pink lump with a pearly consistency. Close-up, it may appear to have prominent blood vessels on its surface.
If it has been present for a long time, the BCC may spread outward and the surface becomes ulcerated or crusted. This is why sores that take a long time to heal are suspicious for skin cancer.
Superficial basal cell carcinoma
Superficial basal cell carcinoma (sBCC) is thin and affects the uppermost level of the skin. It may appear as a pink or red rough patch and can easily be mistaken for dermatitis or another type of rash.
Infiltrative basal cell carcinoma
Infiltrative BCC (also called morpheic BCC) is a less common variant with edges that cannot always be clearly seen. This type of BCC can be difficult to remove surgically and often needs to be removed by a plastic surgeon or dermatologist specialising in Moh's surgery (where the removed tissue is examined microscopically during the procedure to ensure that the entire BCC has been removed)..
What happens if basal cell carcinoma is untreated?
Without treatment, basal cell carcinoma usually grows slowly. It it sometimes present for years before it is noticed.
Basal cell carcinoma tends to remain in one location without spreading to other parts of the body. As it grows, it causes damage to the area, including:
- sores that bleed and don't heal (This type of sore used to be called a rodent ulcer because it looks like the skin has been chewed by a rat or mouse!)
- damage to underlying tissues such as muscles, blood vessels and nerves
How is basal cell carcinoma treated?
Nodular basal cell carcinoma is treated by surgical removal.
Superficial basal cell carcinoma can be treated by surgical removal, application of a cream or cryotherapy (freezing).
Risk factors for BCC
Risk factors for developing basal cell carcinoma include:
- outdoor occupations
- previous radiotherapy
- solarium use
- fair or red hair colour
- skin that burns and does not tan
- tendency to freckle
- a history of blistering sunburn
- a previous BCC
- increasing age
- past exposure to arsenic
Prevention of basal cell carcinoma
People with a history of basal call carcinoma are at high risk of developing future BCCs (as well as having an increased risk of melanoma). Because many of the risk factors for basal cell carcinoma cannot be reversed, prevention of future BCCs can be difficult. Up to 60 per cent of people with BCC will develop another within three year (Cancer Council 2018).
Vitamin B3 (nicotinamide) taken orally has been shown to reduce the rate of basal cell carcinoma and squamous cell carcinoma by 20-30 per cent.